| Thomas E. Polen | Chairman, Chief Executive Officer and President | FY2025 | |
| Christopher J. DelOrefice | Executive Vice President and Chief Financial Officer | FY2025 | |
| Michael C. Feld | Executive Vice President, Chief Revenue Officer and President, Life Sciences Segment | FY2025 | |
| Michael D. Garrison | Executive Vice President and President, Medical Essentials and BioPharma Systems Segments | FY2025 | |
| Richard E. Byrd | Executive Vice President and President, Interventional Segment | FY2025 |
5 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.